Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector
Open Access
- 23 December 2004
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 12 (4) , 320-329
- https://doi.org/10.1038/sj.gt.3302306
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Gene therapy progress and prospects: adenoviral vectorsGene Therapy, 2003
- Ablation of microvessels in vivo upon dimerization of iCaspase-9Gene Therapy, 2002
- Targeting adenovirusGene Therapy, 2000
- Role of endothelial cell survival and death signals in angiogenesisAngiogenesis, 1999
- Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction PathwayJournal of Biological Chemistry, 1998
- Angiogenesis and angiogenesis inhibition: An overviewPublished by Springer Nature ,1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- How Tumors Become AngiogenicAdvances in Cancer Research, 1996
- Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cellsBiochemical and Biophysical Research Communications, 1990
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971